Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Canadian oil and gas company Nexen Inc. (NXY) has missed the deadline for the completion of maintenance work at the Buzzard oil field in the North Sea. Delay in the commissioning of the fourth platform will hamper the company’s production target.
The Buzzard oil field is the key contributor to Forties crude. Moreover, this crude is the most important constituent of benchmark Brent, which is used to price a major portion of the world's oil.
Due to the delay in work, a November cargo – F1104 – has been dropped from the loading program of the Forties.
Production was scheduled to commence in mid October but now it has been postponed by a week.
Calgary, Alberta-based Nexen has a diversified portfolio of exploration and production operations in Canada, the U.S. Gulf of Mexico, North Sea (U.K.), Yemen, Nigeria and other areas. We believe that the company’s multi-year inventory of development projects and endeavors will aid in accomplishing the targeted growth level.
Nexen has been actively investing in its upstream assets in recent years, significantly improving its long-term, production-growth prospect. The production efficiency at Buzzard surpassed the company’s target of 85% and touched 88% in the second quarter of 2012.
Of late, Nexen has been in the news following its purchase deal with Chinese energy giant CNOOC Ltd. (CEO - Analyst Report) last July for approximately $15.1 billion in cash. Per the agreement, which is expected to be wrapped up by this year-end, CNOOC will buy all the outstanding common shares of Nexen at $27.50 per share, representing a premium of 61% to its closing price on the New York Stock Exchange on July 20.
Nexen retains a Zacks #2 Rank, which is equivalent to a Buy rating for the period of one to three months.
Get the full Analyst Report on CEO - FREE